Clinical Trials
4 trialsNCT04458259 2026-06-04
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Pfizer
Phase 1 Terminated
NCT04152863 2024-08-06
V937-011
Merck Sharp & Dohme LLC
Phase 2 Terminated
NCT05709821 2024-04-24
IMM60 and Pembrolizumab in Melanoma and NSCLC
Portage Biotech
Phase 1/2 Terminated
NCT03361228 2020-05-21
A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors
Incyte Corporation
Phase 1/2 Terminated